Modulation of Macrophage Function by Bioactive Wound Dressings with an Emphasis on Extracellular Matrix-Based Scaffolds and Nanofibrous Composites

Tao He, Yuzhen Xiao, Zhijun Guo, Yifeng Shi, Qiuwen Tan, Yizhou Huang, Huiqi XiePharmaceutics 2023 · DOI

TL;DR

This review explores how advanced wound dressings, particularly those based on extracellular matrix (ECM) scaffolds and nanofibrous composites, can be designed to modulate macrophage function. By guiding macrophages towards an anti-inflammatory, pro-healing (M2) phenotype, these dressings offer a promising strategy to accelerate chronic wound healing.

What Problem Does This Paper Address?

Chronic, non-healing wounds are a significant clinical challenge, often stemming from a dysfunctional immune response. Macrophages, key immune cells in wound healing, play a critical role. In normal healing, they transition from an initial pro-inflammatory (M1) state to an anti-inflammatory, tissue-repairing (M2) state. However, in chronic wounds, this transition is often impaired, leading to persistent inflammation and delayed healing. Current wound dressings primarily offer physical protection, but there's a growing need for "bioactive" dressings that actively influence the wound microenvironment to promote healing. This paper addresses the gap by reviewing how engineered biomaterials, specifically ECM-based scaffolds and nanofibrous composites, can be designed to precisely control macrophage behavior for improved wound outcomes.

Methods

This paper is a comprehensive review, not an experimental study. It synthesizes existing research on bioactive wound dressings and their impact on macrophage function. The authors categorize strategies for modulating macrophage behavior into several key areas:

  • Refinement of Scaffold Physical Properties: This includes manipulating pore size, fiber diameter, stiffness, and topography of the scaffold material. The idea is that the physical characteristics of the material can influence how macrophages interact with it, affecting their polarization.
  • Incorporation of Immunomodulatory Agents: This involves adding specific molecules known to influence macrophage behavior, such as cytokines (e.g., IL-4) or chemical compounds with anti-inflammatory properties.
  • Loading with Stem Cells or Their Derivatives: This approach utilizes the inherent immunomodulatory capabilities of stem cells (like MSCs) or their secreted exosomes to influence macrophage polarization.
  • Specific Material Types: The review focuses on two main categories of advanced wound dressings:
  • ECM-Based Scaffolds: These are derived from natural extracellular matrix, aiming to mimic the native tissue environment.
  • Nanofibrous Composites: These materials are engineered at the nanoscale, offering high surface area and tunable properties for drug delivery and cell interaction.

Datasets

Not discussed in the paper. This is a review article summarizing existing literature, not presenting new experimental data or benchmarks.

Key Insights and Ideas

  • Macrophage Plasticity is Key: The ability of macrophages to switch between M1 (pro-inflammatory) and M2 (anti-inflammatory/pro-repair) phenotypes is central to effective wound healing. Dysfunctional polarization is a hallmark of chronic wounds.
  • Bioactive Dressings Go Beyond Protection: The future of wound care lies in dressings that actively orchestrate the healing process, rather than just covering the wound.
  • Physical Cues Matter: The physical characteristics of a scaffold (pore size, fiber diameter, stiffness, topography) can significantly influence macrophage polarization, often in predictable ways (e.g., larger pores favoring M2).
  • ECM Mimicry is Powerful: Natural ECM scaffolds retain bioactive molecules and structural cues that can guide macrophage behavior, making them excellent candidates for wound dressings.
  • Nanofibers Offer Precision: Nanofibrous composites provide a versatile platform for incorporating bioactive agents and controlling release, allowing for fine-tuning of macrophage responses.
  • The "Smart" Dressing Challenge: A major future direction is developing "smart" dressings that can dynamically adapt their immunomodulatory effects based on the stage of wound healing and the local microenvironment, rather than just promoting M2 polarization universally.

Key Results

As a review, this paper doesn't present new quantitative results. Instead, it synthesizes findings from numerous studies, highlighting consistent trends:

  • ECM-based scaffolds derived from various tissues (e.g., pericardium, submucosa) have shown success in promoting wound healing by modulating macrophage polarization towards the M2 phenotype, leading to reduced inflammation, increased angiogenesis, and improved re-epithelialization.
  • Nanofibrous composites incorporating agents like ursolic acid, anemoside B4, or exosomes have demonstrated the ability to suppress M1 polarization, reduce inflammatory cytokines (TNF-α, IL-1β), and promote M2 markers, resulting in accelerated wound closure and tissue regeneration.
  • Studies on scaffold physical properties consistently show that factors like larger pore sizes, thicker fibers, and specific topographies can favor M2 polarization, while smaller pores or thinner fibers might lean towards M1. However, the interplay of these factors can be complex.

Limitations and Future Work

  • Inconsistent Findings: The authors acknowledge that some studies report conflicting results regarding the influence of certain scaffold properties (e.g., stiffness) on macrophage polarization, suggesting that other scaffold characteristics likely play a significant role.
  • Mechanism Understanding: While many studies demonstrate scaffold-mediated polarization, the precise underlying mechanisms are not always fully understood and require further investigation.
  • Clinical Translation: Despite promising preclinical results, there is a significant lack of clinical trials for these advanced bioactive wound dressings.
  • Future Directions:
    • Developing "smart" wound dressings that can dynamically modulate macrophage function according to the wound healing stage.
  • Achieving continuous and ordered coordination of inflammatory and anti-inflammatory macrophage responses.
  • Scaling up the production of cell-derived ECM for clinical applications.
  • Focusing on clinical translation and rigorous testing of these promising biomaterials.

Summary updated

Abstract

Bioactive wound dressings that are capable of regulating the local wound microenvironment have attracted a very large interest in the field of regenerative medicine. Macrophages have many critical roles in normal wound healing, and the dysfunction of macrophages significantly contributes to impaired or non-healing skin wounds. Regulation of macrophage polarization towards an M2 phenotype provides a feasible strategy to enhance chronic wound healing, mainly by promoting the transition of chronic inflammation to the proliferation phase of wound healing, upregulating the level of anti-inflammatory cytokines around the wound area, and stimulating wound angiogenesis and re-epithelialization. Based on this, modulation of macrophage functions by the rational design of bioactive scaffolds has emerged as a promising way to accelerate delayed wound healing. This review outlines current strategies to regulate the response of macrophages using bioactive materials, with an emphasis on extracellular matrix-based scaffolds and nanofibrous composites.
BibTeX
@inproceedings{he2023modulation,
  author = {Tao He and Yuzhen Xiao and Zhijun Guo and Yifeng Shi and Qiuwen Tan and Yizhou Huang and Huiqi Xie},
  title = {{Modulation of Macrophage Function by Bioactive Wound Dressings with an Emphasis on Extracellular Matrix-Based Scaffolds and Nanofibrous Composites}},
  booktitle = {Pharmaceutics},
  year = {2023},
  doi = {10.3390/pharmaceutics15030794},
}
Figure